Behavioral Health Business April 4, 2024
Digital autism company EarliTec Diagnostics has raised $21.5 million in a Series B funding round.
Decatur, Georgia-based EarliTec will use the cash to fund clinical research evaluating its early autism diagnosis technology. The technology aims to aid clinicians in diagnosing and assessing autism in toddlers.
Nexus NeuroTech Ventures and Venture Investors Health Fund led the funding round.
“EarliTec is pioneering diagnostic and treatment solutions for children with autism, and we’re thrilled to support their innovative efforts,” Jim Adox, executive managing director at Venture Investors Health Fund, said in a statement.
Children evaluated using EarliTec’s method watch videos of social interactions on a tablet. An embedded biomarker tracks the child’s focus on the scenes and assesses social disability, verbal ability...
Today's Sponsors
Today's Sponsor